litlas
ログインアカウント作成

Hans W. Nijman

1993–2025 年に発表

95
論文数
20,027
被引用数
63
h 指数
93
i10 指数

被引用数

Hans W. Nijman の年別被引用数1993 年: 被引用 3 件1994 年: 被引用 18 件1995 年: 被引用 31 件1996 年: 被引用 38 件1997 年: 被引用 47 件1998 年: 被引用 44 件1999 年: 被引用 46 件2000 年: 被引用 41 件2001 年: 被引用 42 件2002 年: 被引用 48 件2003 年: 被引用 34 件2004 年: 被引用 38 件2005 年: 被引用 38 件2006 年: 被引用 39 件2007 年: 被引用 34 件2008 年: 被引用 51 件2009 年: 被引用 65 件2010 年: 被引用 71 件2011 年: 被引用 88 件2012 年: 被引用 108 件2013 年: 被引用 110 件2014 年: 被引用 128 件2015 年: 被引用 176 件2016 年: 被引用 213 件2017 年: 被引用 227 件2018 年: 被引用 266 件2019 年: 被引用 744 件2020 年: 被引用 868 件2021 年: 被引用 995 件2022 年: 被引用 856 件2023 年: 被引用 707 件2024 年: 被引用 1,111 件2025 年: 被引用 574 件2026 年: 被引用 22 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,002 件、この内訳の 20.4%中国: 引用元論文 1,474 件、この内訳の 15%イタリア: 引用元論文 572 件、この内訳の 5.8%イギリス: 引用元論文 556 件、この内訳の 5.7%オランダ: 引用元論文 480 件、この内訳の 4.9%フランス: 引用元論文 435 件、この内訳の 4.4%ドイツ: 引用元論文 429 件、この内訳の 4.4%カナダ: 引用元論文 334 件、この内訳の 3.4%スペイン: 引用元論文 303 件、この内訳の 3.1%日本: 引用元論文 290 件、この内訳の 3%オーストラリア: 引用元論文 285 件、この内訳の 2.9%スウェーデン: 引用元論文 186 件、この内訳の 1.9%
0%20.4%その他 25.1%

機関

分野

  • Medicine47.4%
  • Biochemistry, Genetics and Molecular Biology33.9%
  • Immunology and Microbiology15.2%
  • Computer Science0.9%
  • Neuroscience0.7%
  • Engineering0.6%
  • その他1.3%

トピック

  • Extracellular vesicles in disease9.2%
  • Cancer Immunotherapy and Biomarkers7.4%
  • Endometrial and Cervical Cancer Treatments6.3%
  • Immunotherapy and Immune Responses6.3%
  • MicroRNA in disease regulation5.2%
  • Immune Cell Function and Interaction3.8%
  • その他61.8%

共著者

全論文

検索で開く
  1. B lymphocytes secrete antigen-presenting vesicles.

    著者: Graça Raposo, Hans W. Nijman, Willem Stoorvogel, R Liejendekker, Clifford V. Harding, Cornelis J.M. Melief, Hans J. Geuze - The Journal of Experimental Medicine 1996 被引用: 3,474

  2. Tumor-infiltrating lymphocytes in the immunotherapy era

    著者: Sterre T. Paijens, Annegé Vledder, Marco de Bruyn, Hans W. Nijman - Cellular and Molecular Immunology 2020 被引用: 927

  3. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    著者: Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Naveena Singh, Pamela M. Pollock, Paul Bessette, Anthony Fyles, Christine Haie-Méder, Vincent T.H.B.M. Smit, Richard J. Edmondson, Hein Putter, Henry C Kitchener, Emma J. Crosbie, Marco de Bruyn, Remi A. Nout, Nanda Horeweg, Carien L. Creutzberg, Tjalling Bosse - Journal of Clinical Oncology 2020 被引用: 837

  4. Tumour-infiltrating lymphocytes: from prognosis to treatment selection

    著者: Koen Brummel, Anneke L. Eerkens, Marco de Bruyn, Hans W. Nijman - British Journal of Cancer 2022 被引用: 234

  5. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

    著者: Ellen Stelloo, Remi A. Nout, Elisabeth M. Osse, Ina J. Jürgenliemk-Schulz, Jan J. Jobsen, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Hans W. Nijman, Hein Putter, Tjalling Bosse, Carien L. Creutzberg, Vincent T.H.B.M. Smit - Clinical Cancer Research 2016 被引用: 858

  6. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

    著者: Marloes J.M. Gooden, Geertruida H. de Bock, Ninke Leffers, Toos Daemen, Hans W. Nijman - British Journal of Cancer 2011 被引用: 1,293

  7. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up

    著者: Nicoletta Colombo, Carien L. Creutzberg, Frédéric Amant, Tjalling Bosse, Antonio González-Martı́n, Jonathan A. Ledermann, Christian Marth, Remi A. Nout, Denis Querleu, Mansoor Raza Mirza, Cristiana Sessa, Miguel Abal, Özden Altundağ, Frédéric Amant, Antoni Van Leeuwenhoek, Susana Banerjee, Tjalling Bosse, Antonio Casado, L Chiva de Agustín, David Cibula, Nicoletta Colombo, Carien L. Creutzberg, José María Del Campo, Günter Emons, Frédéric Goffin, Antonio González-Martı́n, Stefano Greggi, Christine Haie-Méder, Dionyssios Katsaros, Vesna Kesić, Christian Kurzeder, Sigurd Lax, Fabrice Lécuru, Jonathan A. Ledermann, Tally Levy, Domenica Lorusso, Johanna Mäenpää, Christian Marth, Xavier Matías‐Guiu, Philippe Morice, Hans W. Nijman, Remi A. Nout, Melanie Powell, Denis Querleu, Mansoor Raza Mirza, Nicholas Reed, Alexandros Rodolakis, Helga B. Salvesen, Jalid Sehouli, Cristiana Sessa, Alexandra Taylor, Anneke M. Westermann, Alain G. Zeimet - Annals of Oncology 2015 被引用: 1,380

  8. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

    著者: Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, Mariël Brinkhuis, Suzan Roothaan, Melanie Powell, Stephanie M. de Boer, Pearly Khaw, Linda Mileshkin, Anthony Fyles, Alexandra Léary, Catherine Genestie, Ina M. Jürgenliemk‐Schulz, Emma J. Crosbie, Helen Mackay, Hans W. Nijman, Remi A. Nout, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Stephanie M. de Boer - British Journal of Cancer 2023 被引用: 162

  9. A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer

    著者: Hagma H. Workel, Joyce M. Lubbers, Roland Arnold, Thalina M. Prins, Pieter van der Vlies, Kim de Lange, Tjalling Bosse, Inge C. van Gool, Florine A. Eggink, Maartje C.A. Wouters, Fenne L. Komdeur, Elisabeth C. van der Slikke, Carien L. Creutzberg, Arjan Kol, Annechien Plat, Mark A. Glaire, David N. Church, Hans W. Nijman, Marco de Bruyn - Cancer Immunology Research 2019 被引用: 262

  10. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

    著者: Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J. Jobsen, Mariël Brinkhuis, Suzan Roothaan, Ina J. Jürgenliemk-Schulz, Ludy Lutgens, Remi A. Nout, Elzbieta M. van der Steen‐Banasik, Stephanie M. de Boer, Melanie Powell, Naveena Singh, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Viktor H. Koelzer, Tjalling Bosse - The Lancet Digital Health 2022 被引用: 124

  11. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

    著者: Nanda Horeweg, Hagma H. Workel, Dominik Loiero, David N. Church, Lisa Vermij, Alicia León‐Castillo, Ricki T. Krog, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Ina M. Jürgenliemk‐Schulz, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn, Nanda Horeweg, David N. Church, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Carien L. Creutzberg, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn - Nature Communications 2022 被引用: 144

  12. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

    著者: Lisa Vermij, Alicia León‐Castillo, Naveena Singh, Melanie Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Léary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Nanda Horeweg, Stephanie M. de Boer, Carien L. Creutzberg, Tjalling Bosse, Vincent T.H.B.M. Smit, Judith R. Kroep, Remi A. Nout, Hans W. Nijman, Marco de Bruyn, Melanie Powell, Naveena Singh, H. Kitchener, Emma J. Crosbie, Richard J. Edmondson, David N. Church, Alexandra Léary, Linda Mileshkin, Pamela M. Pollock, Helen Mackay - Modern Pathology 2022 被引用: 161

  13. PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

    著者: Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A. Nout, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Henrike Westerveld, Hetty A. van den Berg, Annerie Slot, Friederike Koppe, Stefan Kommoss, Jan Willem Mens, Marlies E. Nowee, S. Bijmolt, David Cibula, Tanja C. Stam, Ina M. Jürgenliemk‐Schulz, An Snyers, Moritz Hamann, A.G. Zwanenburg, V. Coen, Katrien Vandecasteele, Charles Gillham, Cyrus Chargari, Karen Verhoeven-Adema, Hein Putter, Wilbert B. van den Hout, Bastiaan G. Wortman, Hans W. Nijman, Tjalling Bosse, Carien L. Creutzberg - International Journal of Gynecological Cancer 2020 被引用: 248

  14. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

    著者: Ellen Stelloo, Tjalling Bosse, Remi A. Nout, Helen Mackay, David N. Church, Hans W. Nijman, Alexandra Léary, Richard J. Edmondson, Melanie Powell, Emma J. Crosbie, Henry C Kitchener, Linda Mileshkin, Pamela M. Pollock, Vincent T.H.B.M. Smit, Carien L. Creutzberg - Modern Pathology 2015 被引用: 490

  15. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    著者: Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Méder, Petronella B. Ottevanger, Jonathan A. Ledermann, Pearly Khaw, Romerai D’Amico, Anthony Fyles, Marie‐Hélène Baron, Ina M. Jürgenliemk‐Schulz, Henry C Kitchener, Hans W. Nijman, Godfrey Wilson, Susan A. Brooks, Sergio Gribaudo, Diane Provencher, C. Hanzen, Roy F.P.M. Kruitwagen, Vincent T.H.B.M. Smit, Naveena Singh, Viet Do, Andrea Alberto Lissoni, Remi A. Nout, Amanda Feeney, Karen Verhoeven-Adema, Hein Putter, Carien L. Creutzberg, Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, LCHW Lutgens, Harry Hollema, E. Pras, An Snyers, Henrike Westerveld, JJ Jobsen, Annerie Slot, JM Mens, TC Stam, Baukelien van Triest, E. van der Steen-Banasik, K. Winter, MA Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Alessandro Colombo, Silvestro Carinelli, Annamaria Ferrero, Grazia Artioli, Catherine Davidson, C. Meg McLachlin, Prafull Ghatage, PVC Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, D Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2019 被引用: 456

  16. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

    著者: Enric Domingo, Luke Freeman-Mills, Emily Rayner, Mark A. Glaire, Sarah Briggs, Louis Vermeulen, Evelyn Fessler, Jan Paul Medema, Arnoud Boot, Hans Morreau, Tom van Wezel, Gerrit‐Jan Liefers, Ragnhild A. Lothe, Stine A. Danielsen, Anita Sveen, Arild Nesbakken, Inti Zlobec, Alessandro Lugli, Viktor H. Koelzer, Martin D. Berger, Sergi Castellvı́-Bel, Jenifer Muñoz, Marco de Bruyn, Hans W. Nijman, Marco Novelli, Kay Lawson, Dahmane Oukrif, Eleni Frangou, Peter Dutton, Sabine Tejpar, Mauro Delorenzi, Rachel Kerr, David Kerr, Ian Tomlinson, David N. Church - ˜The œLancet. Gastroenterology & hepatology 2016 被引用: 309

  17. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    著者: Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Dionyssios Katsaros, Paul Bessette, Christine Haie-Méder, Petronella B. Ottevanger, Jonathan A. Ledermann, Pearly Khaw, Alessandro Colombo, Anthony Fyles, Marie‐Hélène Baron, Ina M. Jürgenliemk‐Schulz, Henry C Kitchener, Hans W. Nijman, Godfrey Wilson, Susan A. Brooks, Silvestro Carinelli, Diane Provencher, C. Hanzen, Ludy Lutgens, Vincent T.H.B.M. Smit, Naveena Singh, Viet Do, Romerai D’Amico, Remi A. Nout, Amanda Feeney, Karen Verhoeven-Adema, Hein Putter, Carien L. Creutzberg, Mary McCormack, Karen Whitmarsh, R. Allerton, D. Gregory, Paul Symonds, Peter Hoskin, Madhavi Adusumalli, Anjana Anand, Robert Wade, Alexandra Stewart, W. Chris Taylor, Roy F.P.M. Kruitwagen, Harry Hollema, E. Pras, An Snyers, Lukas L Stalpers, Jan J. Jobsen, Annerie Slot, Jan-Willem M. Mens, Tanja C. Stam, Baukelien van Triest, Elzbieta M. Van der Steen - Banasik, Karin A.J. De Winter, Michael Quinn, Ilka Kolodziej, Jan Pyman, Carol Johnson, Anne Capp, Roldano Fossati, Sergio Gribaudo, Andrea Alberto Lissoni, Annamaria Ferrero, Grazia Artioli, Cathy N. Davidson, C. Meg McLachlin, Prafull Ghatage, Paula V.C. Rittenberg, Luís Souhami, Gillian Thomas, Pierre Duvillard, Dominique Berton-Rigaud, N. Tubiana-Mathieu - The Lancet Oncology 2018 被引用: 623

  18. A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

    著者: E. M. Dijkgraaf, Saskia J. Santegoets, A.K.L. Reyners, Renske Goedemans, Maartje C.A. Wouters, Gemma G. Kenter, Arien R. van Erkel, Mariëtte I.E. van Poelgeest, Hans W. Nijman, Jacobus J. M. van der Hoeven, Marij J.P. Welters, Sjoerd H. van der Burg, Judith R. Kroep - Annals of Oncology 2015 被引用: 193

  19. Prediction of recurrence risk in endometrial cancer with multimodal deep learning

    著者: Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W. Lafarge, Cor D. de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J. Jobsen, Ludy Lutgens, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Dionyssios Katsaros, Hans W. Nijman, Stephanie M. de Boer, Remi A. Nout, Marco de Bruyn, David N. Church, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Tjalling Bosse - Nature Medicine 2024 被引用: 88

  20. Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

    著者: Oana Draghiciu, Joyce M. Lubbers, Hans W. Nijman, Toos Daemen - OncoImmunology 2014 被引用: 272

  21. Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

    著者: Cornelis J.M. Melief, Marij J.P. Welters, Ignace Vergote, Judith R. Kroep, Gemma G. Kenter, Petronella B. Ottevanger, Wiebren Tjalma, Hannelore Denys, Mariëtte I.E. van Poelgeest, Hans W. Nijman, Anna K.L. Reyners, Thierry Velu, Frédéric Goffin, Roy Lalisang, Nikki M. Loof, Sanne Boekestijn, Willem Jan Krebber, Leon Hooftman, Sonja Visscher, Brent A. Blumenstein, Richard B. Stead, Winald R. Gerritsen, Sjoerd H. van der Burg - Science Translational Medicine 2020 被引用: 134

  22. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy

    著者: for the PORTEC Study Group, Bastiaan G. Wortman, Carien L. Creutzberg, Hein Putter, I.M. Jürgenliemk-Schulz, Jan J. Jobsen, Ludy Lutgens, Elzbieta M. van der Steen‐Banasik, Jan Willem Mens, Annerie Slot, Marika C. Stenfert Kroese, Baukelien van Triest, Hans W. Nijman, Ellen Stelloo, Tjalling Bosse, Stephanie M. de Boer, Wim L.J. van Putten, Vincent T.H.B.M. Smit, Remi A. Nout - British Journal of Cancer 2018 被引用: 282

  23. Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer

    著者: Frank M. Speetjens, Peter J.K. Kuppen, Marij J.P. Welters, Farah Essahsah, Anne Marie E.G. Voet van den Brink, M. Graziella Kallenberg Lantrua, A. Rob P.M. Valentijn, Jaap Oostendorp, Lorraine M. Fathers, Hans W. Nijman, Jan W. Drijfhout, Cornelis J.�H. van de Velde, Cornelis J.M. Melief, Sjoerd H. van der Burg - Clinical Cancer Research 2009 被引用: 179

  24. First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

    著者: Fenne L. Komdeur, Amrita Singh, Stephanie van de Wall, J. J. M. Meulenberg, Annemarie Boerma, Baukje Nynke Hoogeboom, Sterre T. Paijens, César Oyarce, Marco de Bruyn, Ed Schuuring, Joke Regts, R.B. Marra, Naomi Werner, J. J. A. Sluis, Ate G.J. van der Zee, Jan Wilschut, Derk P. Allersma, Coba J. van Zanten, Jos G. W. Kosterink, Annelies Jorritsma‐Smit, Refika Yigit, Hans W. Nijman, Toos Daemen - Molecular Therapy 2020 被引用: 82